Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

First new narcolepsy therapy in decades cleared in U.K.

Oct. 21, 1997

Dexanabinol: pharmacokinetics in humans

Oct. 21, 1997

New formulation of diazepam launched in U.S.

Oct. 21, 1997

Further indications of divalproex efficacy in dementia

Oct. 21, 1997

CoCensys receives NIH grant to develop caspase inhibitors

Oct. 21, 1997

Ginkgo biloba extract stabilizes dementia in patients in U.S. trial

Oct. 21, 1997

Peripheral and Central Nervous System Drugs Advisory Committee meets next month

Oct. 20, 1997

Toyama to begin U.S. development of Alzheimer's drug

Oct. 20, 1997

Warner-Lambert prepares new cyclic amino acids related to gabapentin

Oct. 20, 1997

U-101033E vs. U-74389G in rat model of focal cerebral ischemia

Oct. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...